Global Patients is working with Evidera, a scientific research company, to conduct a study about participant perspective in Relapsed/Refractory Diffuse large B-cell Lymphoma (R/R DLBCL) and Follicular Lymphoma (FL). The sponsor of the study is a global pharmaceutical company.

Participants will participate in a 60min interview and complete a brief questionnaire so we can better understand participant experiences of R/R DLBCL and FL. The study does not involve any treatments; we are only interested in opinions.

As compensation for their time, participants will receive a payment of 160USD after completing the 60min interview and questionnaire.

If you are interested in more information about this study or would like to schedule a call to determine your eligibility, please contact us at

Please do not provide any information about your health in your initial message.

Join this Study
Are you already a member of Global Patients?